NEW YORK (GenomeWeb News) – GeneNews last night reported that its first-quarter revenues were flat year over year, while the firm cut its net loss 23 percent.

The Toronto-based genetic test maker brought in revenues of C$300,000 (US$255,000) for the three months ended March 31, the same amount it reported for the first quarter of 2008. GeneNews said that revenues for the quarter were derived from sales of its ColonSentry test for assessing an individual's risk for colorectal cancer, as well as a technology access fee it received from an unnamed company.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.